{"id":234503,"date":"2026-09-08T13:12:54","date_gmt":"2026-09-08T07:42:54","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=234503"},"modified":"2026-09-08T13:12:56","modified_gmt":"2026-09-08T07:42:56","slug":"is-amanta-healthcare-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Amanta Healthcare a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Amanta Healthcare share price around Rs 202. 1.8% below 52-week high of Rs 206. Q1 FY27 revenue Rs 69 crore, up 5.4% YoY. PAT Rs 3.30 crore, down 5.7%. PE 53x.<\/em><\/p>\n<div style=\"background: #F0F9FF; border-left: 4px solid #2E7D32; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0; color: #1f4e79; font-size: 14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin: 8px 0 0;\">Amanta Healthcare&#8217;s Q1 FY27 results were mixed, with revenue at Rs 69 crore but PAT falling 6% to Rs 3.30 crore. The Amanta Healthcare share price near Rs 202 has not escaped this pressure, and the profit decline is the key data point investors should weigh before deciding whether Amanta Healthcare is a good buy right now.<\/p>\n<\/div>\n<p>The Amanta Healthcare share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Amanta Healthcare is a manufacturer of sterile liquid pharmaceutical products including IV fluids and ophthalmic solutions, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n<p>Revenue for the quarter came in at Rs 69 crore, up 5.4% year on year, while profit after tax came in at Rs 3.30 crore, down 5.7% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Amanta Healthcare share price from here.<\/p>\n<p>This piece works through the quarter&#8217;s financial highlights, the business factors behind the numbers, where the Amanta Healthcare share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=amanta-healthcare_q1fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Amanta_Healthcare_Q1_FY27_Financial_Highlights\" title=\"Amanta Healthcare Q1 FY27 Financial Highlights\">Amanta Healthcare Q1 FY27 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Amanta_Healthcare_Q1_FY27_Performance_Analysis\" title=\"Amanta Healthcare Q1 FY27 Performance Analysis\">Amanta Healthcare Q1 FY27 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Key_Business_Factors_in_Q1_FY27\" title=\"Key Business Factors in Q1 FY27\">Key Business Factors in Q1 FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Revenue_Trend\" title=\"Revenue Trend\">Revenue Trend<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Margin_Movement\" title=\"Margin Movement\">Margin Movement<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Balance_Sheet_Position\" title=\"Balance Sheet Position\">Balance Sheet Position<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Valuation_Context\" title=\"Valuation Context\">Valuation Context<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Dividend_Details\" title=\"Dividend Details\">Dividend Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Amanta_Healthcare_Share_Price_Outlook_for_FY27\" title=\"Amanta Healthcare Share Price Outlook for FY27\">Amanta Healthcare Share Price Outlook for FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Amanta_Healthcare_Stock_Performance\" title=\"Amanta Healthcare Stock Performance\">Amanta Healthcare Stock Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Key_Risks\" title=\"Key Risks\">Key Risks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Profitability_Risk\" title=\"Profitability Risk\">Profitability Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Sector_and_Demand_Risk\" title=\"Sector and Demand Risk\">Sector and Demand Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Execution_Risk\" title=\"Execution Risk\">Execution Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Frequently_Asked_Questions_on_Amanta_Healthcare_Q1_FY27_Results\" title=\"Frequently Asked Questions on Amanta Healthcare Q1 FY27 Results\">Frequently Asked Questions on Amanta Healthcare Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#What_were_Amanta_Healthcares_Q1_FY27_results\" title=\"What were Amanta Healthcare&#8217;s Q1 FY27 results?\">What were Amanta Healthcare&#8217;s Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Is_Amanta_Healthcare_a_good_buy_after_its_Q1_FY27_results\" title=\"Is Amanta Healthcare a good buy after its Q1 FY27 results?\">Is Amanta Healthcare a good buy after its Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#What_is_the_Amanta_Healthcare_share_price_today\" title=\"What is the Amanta Healthcare share price today?\">What is the Amanta Healthcare share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#What_is_Amanta_Healthcares_revenue_and_profit_for_Q1_FY27\" title=\"What is Amanta Healthcare&#8217;s revenue and profit for Q1 FY27?\">What is Amanta Healthcare&#8217;s revenue and profit for Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#Did_Amanta_Healthcare_declare_a_dividend_with_its_Q1_FY27_results\" title=\"Did Amanta Healthcare declare a dividend with its Q1 FY27 results?\">Did Amanta Healthcare declare a dividend with its Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#What_is_Amanta_Healthcares_PE_ratio_and_is_it_expensive\" title=\"What is Amanta Healthcare&#8217;s PE ratio and is it expensive?\">What is Amanta Healthcare&#8217;s PE ratio and is it expensive?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#What_are_the_key_risks_for_Amanta_Healthcare_investors_right_now\" title=\"What are the key risks for Amanta Healthcare investors right now?\">What are the key risks for Amanta Healthcare investors right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results\/#What_is_Amanta_Healthcares_promoter_shareholding\" title=\"What is Amanta Healthcare&#8217;s promoter shareholding?\">What is Amanta Healthcare&#8217;s promoter shareholding?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Amanta_Healthcare_Q1_FY27_Financial_Highlights\"><\/span><strong>Amanta Healthcare Q1 FY27 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse;\">\n<thead>\n<tr style=\"background: #F0F0F0;\">\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">Metric<\/th>\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">Q1 FY27<\/th>\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">Q1 FY26<\/th>\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Revenue<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 69 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 65 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">5.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">EBITDA<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 14 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 15 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">-2.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Operating Margin<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">21.1%<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">22.8%<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">NA<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Net Profit \/ (Loss)<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 3.30 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 3.50 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">-5.7%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Amanta_Healthcare_Q1_FY27_Performance_Analysis\"><\/span><strong>Amanta Healthcare Q1 FY27 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Amanta Healthcare Fundamentals on Univest Screener<\/strong><\/a><\/p>\n<p>Revenue growth of 5.4% for the quarter came from steady demand across the company&#8217;s core business, keeping the topline trend intact for the sterile liquid pharmaceutical manufacturing sector.<\/p>\n<p>Profitability is where the quarter disappointed. PAT fell 6% year on year to Rs 3.30 crore even as revenue grew, which points to margin or cost pressure that management will need to address. This gap between top-line and bottom-line performance is the key thing weighing on the Amanta Healthcare share price this quarter.<\/p>\n<p>Sequential quarterly data was not fully available for this comparison, so investors should track the next quarter&#8217;s results to build out the trend behind the Amanta Healthcare share price.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_in_Q1_FY27\"><\/span><strong>Key Business Factors in Q1 FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_Trend\"><\/span><strong>Revenue Trend<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Amanta Healthcare&#8217;s revenue grew 5.4% year on year this quarter, taking the quarterly base to Rs 69 crore in a sterile liquid pharmaceutical manufacturing business that remains sensitive to demand and pricing cycles that ultimately feed through to the Amanta Healthcare share price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Margin_Movement\"><\/span><strong>Margin Movement<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>EBITDA fell to Rs 14 crore from Rs 15 crore, with operating margin slipping to 21.1% from 22.8%, pointing to cost or pricing pressure that management will need to manage through the rest of FY27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Balance_Sheet_Position\"><\/span><strong>Balance Sheet Position<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Amanta Healthcare&#8217;s balance sheet metrics were not fully available for this quarter and should be checked against the company&#8217;s official filings before making an investment decision.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_Context\"><\/span><strong>Valuation Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Amanta Healthcare does not carry a meaningful PE multiple this quarter given its current earnings, so investors should lean on revenue and book value trends instead of the price-to-earnings ratio when assessing the Amanta Healthcare share price.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dividend_Details\"><\/span><strong>Dividend Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No interim dividend was declared alongside Amanta Healthcare&#8217;s Q1 FY27 results. The stock has not paid a meaningful dividend in the trailing twelve months. Investors tracking the Amanta Healthcare share price for income should watch the company&#8217;s announcements around its next annual results for any dividend decision.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Amanta_Healthcare_Share_Price_Outlook_for_FY27\"><\/span><strong>Amanta Healthcare Share Price Outlook for FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The key question for the rest of FY27 is whether Amanta Healthcare can arrest the margin pressure seen this quarter. Revenue growth alone will not be enough to support the Amanta Healthcare share price if profitability keeps slipping, so investors should watch the next couple of quarters for signs of a turnaround in the bottom line.<\/p>\n<p>A stabilising or improving margin trend in the next result would be the clearest signal that this quarter&#8217;s profit decline was a temporary setback rather than the start of a longer slide for the Amanta Healthcare share price.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Amanta_Healthcare_Stock_Performance\"><\/span><strong>Amanta Healthcare Stock Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Amanta Healthcare&#8217;s live share price and get daily stock updates.<\/em><\/p>\n<p>The Amanta Healthcare share price was trading around Rs 202 as results season played out in late August 2026, roughly 1.8% below its 52-week high of Rs 206 and well above its 52-week low of Rs 92.<\/p>\n<p>The Amanta Healthcare share price has likely already absorbed some of this quarter&#8217;s disappointment, but further downside is possible if the next results confirm the same trend rather than a one-off.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks\"><\/span><strong>Key Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Profitability_Risk\"><\/span><strong>Profitability Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The quarter&#8217;s profit trend is the clearest risk here. Until Amanta Healthcare shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Sector_and_Demand_Risk\"><\/span><strong>Sector and Demand Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As a sterile liquid pharmaceutical manufacturing business, Amanta Healthcare&#8217;s results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Amanta Healthcare share price well before the next result.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Execution_Risk\"><\/span><strong>Execution Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustaining this quarter&#8217;s trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Amanta Healthcare&#8217;s Q1 FY27 results show a business still growing its top line but losing ground on profitability, with PAT down 6% to Rs 3.30 crore even as revenue rose. The Amanta Healthcare share price reflects a stock in wait-and-watch mode, and it is not an obvious buy purely on this quarter&#8217;s numbers until the margin trend turns around.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Amanta_Healthcare_Q1_FY27_Results\"><\/span><strong>Frequently Asked Questions on Amanta Healthcare Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_were_Amanta_Healthcares_Q1_FY27_results\"><\/span><strong>What were Amanta Healthcare&#8217;s Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Amanta Healthcare reported Q1 FY27 revenue of Rs 69 crore, up 5.4% year on year, and PAT of Rs 3.30 crore, down 5.7% year on year.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Amanta_Healthcare_a_good_buy_after_its_Q1_FY27_results\"><\/span><strong>Is Amanta Healthcare a good buy after its Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Amanta Healthcare&#8217;s profitability came under pressure this quarter, which makes this a stock to watch rather than an obvious buy purely on this result. Investors should form their own view based on their own risk appetite and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Amanta_Healthcare_share_price_today\"><\/span><strong>What is the Amanta Healthcare share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Amanta Healthcare share price was trading around Rs 202 in late August 2026, about 1.8% below its 52-week high of Rs 206 and well above its 52-week low of Rs 92.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Amanta_Healthcares_revenue_and_profit_for_Q1_FY27\"><\/span><strong>What is Amanta Healthcare&#8217;s revenue and profit for Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Amanta Healthcare reported revenue of Rs 69 crore and a net profit of Rs 3.30 crore for the quarter ended June 30, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Amanta_Healthcare_declare_a_dividend_with_its_Q1_FY27_results\"><\/span><strong>Did Amanta Healthcare declare a dividend with its Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No interim dividend was declared alongside Amanta Healthcare&#8217;s Q1 FY27 results. Investors should track the company&#8217;s next annual results for any dividend announcement.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Amanta_Healthcares_PE_ratio_and_is_it_expensive\"><\/span><strong>What is Amanta Healthcare&#8217;s PE ratio and is it expensive?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Amanta Healthcare share price trades at a trailing PE of 52.5x. Investors should compare this with the company&#8217;s growth rate before judging value.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_for_Amanta_Healthcare_investors_right_now\"><\/span><strong>What are the key risks for Amanta Healthcare investors right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The quarter&#8217;s profit trend is the clearest risk here. Until Amanta Healthcare shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results. Sustaining this quarter&#8217;s trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Amanta_Healthcares_promoter_shareholding\"><\/span><strong>What is Amanta Healthcare&#8217;s promoter shareholding?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Promoter shareholding data for Amanta Healthcare was not fully available for this quarter and should be checked on the company&#8217;s official filings.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Amanta Healthcare Q1 FY27: revenue Rs 69 crore, PAT Rs 3.30 crore. Full results breakdown and whether the stock is a buy at current levels.<\/p>\n","protected":false},"author":36,"featured_media":234501,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[3802],"class_list":["post-234503","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["234501"],"_edit_lock":["1788853378:36"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["24"],"rank_math_seo_score":["70"],"rank_math_title":["Amanta Healthcare Share Price: Good Buy After Q1 FY27 Results?"],"rank_math_description":["Amanta Healthcare share price in focus after Q1 FY27 results: PAT down 6% to Rs 3.30 crore, revenue at Rs 69 crore. Full results breakdown and valuation check inside."],"rank_math_focus_keyword":["Amanta Healthcare share price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["36"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["42214"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/is-amanta-healthcare-a-good-buy-after-q1-fy27-results.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/234503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=234503"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/234503\/revisions"}],"predecessor-version":[{"id":235052,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/234503\/revisions\/235052"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/234501"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=234503"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=234503"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=234503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}